到百度首页
百度首页
贵阳男子白癜风医院
播报文章

钱江晚报

发布时间: 2025-05-24 15:06:32北京青年报社官方账号
关注
  

贵阳男子白癜风医院-【贵州白癜风皮肤病医院】,贵州白癜风皮肤病医院,贵阳市哪个医院治白癜风强,贵阳治白癜风较好的专业医院,赤水哪里治白癜风最好,贵阳那点检查白癜风更专业,贵阳看白癜风哪里比较好,贵阳治疗白癜风哪家医院专业

  

贵阳男子白癜风医院毕节治疗白癜风最好医院是哪家,贵阳治疗白殿疯大概多少钱,贵阳那个医院主治白癜风,贵阳那里治疗白癜风效果更好,贵阳找白癜风,贵阳哪所医院看白癜风好些,贵阳白癜风医院白癜风

  贵阳男子白癜风医院   

BRUSSELS, April 29 (Xinhua) -- As a 2004 European Union (EU) directive on herbal medicine is to be fully implemented on May 1, herbal medicinal products without a license will no longer be allowed in the EU market, the European Commission said in a press release Friday.The Traditional Herbal Medicinal Products Directive, adopted by the EU member states in 2004, introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to obtain a medicine license.As the transition period is to expire on Saturday, herbal medicinal products from home and abroad, most of which have been sold as food supplements for decades, need to be medically registered or authorized by EU governments in order to remain in the market after May 1.Instead of going through safety tests and clinical trials as regular chemical drugs, applicants are required by the directive to provide documents showing the herbal medicinal product is not harmful in the specified condition of use, as well as evidence that the product at least has a 30-year history of safe use, including 15 years in the EU.However, a wide range of eligibility and technical challenges along with prohibitive costs have so far prevented both local and outside herbal medicinal products from being granted the license.Only a small proportion of indigenous herbal medicinal products have been approved for registration while not a single Chinese or Indian traditional herbal medicinal products have been licensed.Lack of pan-European rules, EU member states had adopted different approaches to herbal medicine, thus creating a "state of anarchy" in the markets despite the fact that indigenous herbs had a 700-year history of use in Europe.Although the directive was intended to harmonize rules of member states and build a level-playing field across the EU, critics argued that the directive may fall short of the aim and create more chaos and uncertainties for the industry.DRAWBACKSThe directive has been under attack for being neither "adequate " nor "appropriate" due to its high registration cost for a single product and its lack of consideration about the Chinese and Indian traditional herbal medicine.Chris Dhaenens, a licensed herbalist in Belgium and a shareholder of a medium-sized herbal importing company doing business with China and ten European countries, said the directive was only appropriate for companies carrying a few products and who could afford the registration costs."It is simply inaccessible to most players distributing high- quality Chinese or Indian herbal products in Europe," he said, adding that the registration fee for a single product could be as high as 150,000 euros.The Alliance for Natural Health, a British-based group representing herbal practitioners, estimated the cost of obtaining a license at between 80,000 and 120,000 pounds (90,000 to 135,000 U.S. dollars) per herb.Dhaenens, who is also the president of the European Benefyt Foundation, a leading traditional medicine group in Europe, argued that the directive only tried to regulate herbal products instead of its practitioners and the whole herbal system, as well as fell short to take the Chinese and Indian traditional medicine into full consideration.Even the European Commission had admitted that the directive was not fit for the registration of Chinese and Indian medicine in an earlier exchange with the European Medicine Agency in Dec. 2008, Dhaenens revealed in an exclusive interview with Xinhua."But they had no money or time to work out an alternative, and so it was left to the member states," he said.

  贵阳男子白癜风医院   

CHANGSHA, Jan. 25 (Xinhua) -- More than 8,000 fake goods were destroyed Tuesday in central China's Hunan Province, as part of Chinese efforts to protect intellectual property rights (IPR).Supervised by Changsha customs official, trucks rolled over a huge pile of counterfeit electronic devices in the city, the provincial capital.The trucks crashed imitation Nokia, Motorola and Apple laptop computers, cell phones, earphones and compact discs.Pirated books and Gucci handbags were incinerated.Changsha customs have confiscated more than 34,000 fake items worth 1.3 million yuan (197,470 U.S. dollars) over the past two years, said Liu Zili, a customs official.Some confiscated fake goods were donated to Red Cross societies and quake-devastated regions, in accordance with China's IPR protection regulations.

  贵阳男子白癜风医院   

BEIJING, March 24 (Xinhuanet) -- A new study has found that many overweight women and children often underestimate how heavy they are, according to media reports Wednesday.The study, conducted by researchers from Columbia University Medical Center in New York City, surveyed 111 women with the average age of 39 and 111 children aged between 7 and 13.Among the participants, about 66 percent of the women and 39 percent of the kids were overweight or obese.They were shown images of different body silhouettes representing a range of weights, including underweight, normal weight, overweight, obese and extremely obese.The research findings showed that 82 percent of obese women and 43 percent of overweight women underestimated their weight, while only 13 percent of normal weight women did so.As to the children group, about 86 percent overweight or obese kids low-balled their weight.Lead author Dr. Nicole Dumas said, "The implications of this is the overwhelming impact of obesity on children who are growing up in communities where obesity and overweight is the norm rather than the exception."  She added, "Strategies to overcome the obesity epidemic will need to address this barrier to weight loss."

  

WASHINGTON, April 25 (Xinhua) -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.Working in cell lines from colorectal cancer patients, researchers found that the class of drugs called PARP inhibitors worked against tumors with mutations in the MRE11 gene.About 15 percent of all colorectal cancers have what's called microsatellite instability, a type of error in the DNA. About 82 percent of those tumors have the MRE11 gene mutation."This is a potential broader application for PARP inhibitors, beyond breast and ovarian cancer. This is a class of drug that's already shown safety in early clinical trials and now might benefit some colorectal cancer patients as well," says lead study author Eduardo Vilar-Sanchez, a hematology/oncology fellow at the university, in a statement.The study, which was published Monday in Cancer Research, also found that PARP inhibitors are even more effective when both copies of MRE11 were mutated. Each person carries two copies of each gene, which means mutations can occur in either one or both copies. The researchers suggest that PARP inhibitors could be targeted specifically to colorectal cancer patients who have two copies of the mutated gene.Researchers are planning a phase I clinical trial to look at using PARP inhibitors in colorectal cancer patients with two mutated copies of MRE11. Future trials are being considered using PARP inhibitors to prevent colorectal cancer and other cancers in people with Lynch syndrome whose tumors have this mutation.Microsatellite instability is also seen in prostate cancer and endometrial cancer, suggesting potential for PARP inhibitors to play a role in additional types of cancer as well, Vilar-Sanchez says, adding that more research is needed in these areas.

  

NEW DELHI, March 16 (Xinhua) -- The Indian government has ordered food originating from Japan to be tested for radiation in the wake of explosions at a Japanese nuclear plant following a devastating earthquake-tsunami last Friday, reported local media Wednesday.Authorized officers of Food Safety and Standards Authority of India (FSSAI) at Indian ports, airports have been asked by the government to get food originating from Japan after March 11, 2011 to be tested for radiation, according to Press Trust of India.The Department of Revenue, Government of India, has also been requested to advise all the customs points in the country where imported food is cleared, to test samples on similar lines, according to the report.

举报/反馈

发表评论

发表